For the last several months, and throughout the majority of the NFL season, the Kansas City skyline has illuminated a deep cardinal red and golden hue in honor of the Chiefs. However, things will ...
Feb. 15 is International Angelman Syndrome Day, and the Synk family aims to raise awareness and honor people with the rare ...
Hosted on MSN1d
The special reason Terminal Tower will be blue on SaturdayFeb. 15 is International Angelman Syndrome Day, and the Synk family aims to raise awareness and honor people with the rare ...
Total Revenue of $560 million, exceeding guidanceCrysvita® revenue of $410 million and Dojolvi® revenue of $88 million2025 Financial ...
Angelman Syndrome is a very rare neurogenetic disorder that occurs in approximately one in 15,000 births, caused by the loss of function of a gene ...
The move will provide funds to advance ETX101, a gene therapy the company is developing for SCN1A-positive Dravet syndrome, among other programs.
Encoded Therapeutics is shrinking its headcount by 29% as the gene therapy biotech draws resources away from its early-stage ...
Rare diseases have become an attractive target for pharmaceutical companies both in Australia and internationally with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback